Prof. Dr. Özdarendeli, Director of Erciyes University Vaccine Research and Development Application and Research Center (ERAGEM), reminded that the domestically produced inactivated vaccine TURKOVAC was developed within 18 months under pandemic conditions.
“We are currently conducting studies on TURKOVAC related to new variants as well. We are testing different combinations in terms of research,” stated Özdarendeli, who also shared that efforts to develop a vaccine against Crimean-Congo Hemorrhagic Fever (CCHF) will be resumed.
